Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
British Journal of Cancer
|
September 6, 2012
Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma
G Sonpavde, T K Choueiri
British Journal of Cancer
|
October 29, 2014
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
P Ghatalia, Y Je, M D Kaymakcalan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2011
Randomized phase III trials of second-line chemotherapy in patients with advanced bladder cancer: progress and pitfalls
J Bellmunt, T K Choueiri, F A B Schutz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2010
Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
F A B Schutz, Y Je, G R Azzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2006
Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer
T K Choueiri, T Mekhail, T E Hutson, et al.
British Journal of Cancer
|
October 17, 2013
The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine
L C Harshman, R Fougeray, T K Choueiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2013
Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
J Bellmunt, R Fougeray, J E Rosenberg, et al.
Acta Haematologica
|
December 7, 2006
Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma
R Baz, E Walker, T K Choueiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 11, 2013
Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms
R J Motzer, T Johnson, T K Choueiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
T K Choueiri, S K Pal, D F McDermott, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
British Journal of Cancer
|
September 6, 2012
Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma
G Sonpavde, T K Choueiri
British Journal of Cancer
|
October 29, 2014
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
P Ghatalia, Y Je, M D Kaymakcalan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2011
Randomized phase III trials of second-line chemotherapy in patients with advanced bladder cancer: progress and pitfalls
J Bellmunt, T K Choueiri, F A B Schutz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2010
Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
F A B Schutz, Y Je, G R Azzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2006
Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer
T K Choueiri, T Mekhail, T E Hutson, et al.
British Journal of Cancer
|
October 17, 2013
The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine
L C Harshman, R Fougeray, T K Choueiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2013
Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
J Bellmunt, R Fougeray, J E Rosenberg, et al.
Acta Haematologica
|
December 7, 2006
Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma
R Baz, E Walker, T K Choueiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 11, 2013
Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms
R J Motzer, T Johnson, T K Choueiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
T K Choueiri, S K Pal, D F McDermott, et al.
Page
of 7